Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo

Stem Cells
Markus C DoeserGuangming Wu

Abstract

Transient expression of the transcription factors OCT4, SOX2, KLF4, and C-MYC (OSKM) to induce partial reprogramming while avoiding the pluripotent state and teratoma formation has recently been discussed as a strategy for regenerating damaged tissues in vivo, whereby the impact of partial reprogramming on tissue repair remains to be elucidated. Here, we activated OSKM transcription factors in cutaneous wounds of OSKM-inducible transgenic mice and found that induction of OSKM factors in excisional wounds caused a diminished fibroblast transdifferentiation to myofibroblasts and wound contraction. Gene expression analyses showed downregulation of the profibrotic marker genes transforming growth factor beta 1, Collagen I, and vascular endothelial growth factor. Consequently, histological analyses demonstrated that OSKM induction in incisional wounds resulted in reduced scar tissue formation. These data provide proof of concept that OSKM-mediated partial reprogramming in situ can diminish fibrosis and improve tissue healing with less scar formation without the risk of tumor formation. This new insight into the effects of partial reprogramming in vivo may be relevant for developing reprogramming-based regenerative therapies for tiss...Continue Reading

References

Mar 23, 1979·Virchows Archiv. A, Pathological Anatomy and Histology·U Rowlatt
Sep 1, 1991·Developmental Biology·D J Whitby, M W Ferguson
Apr 1, 1988·Proceedings of the Society for Experimental Biology and Medicine·J R MerkelD C Rice
May 1, 1994·Differentiation; Research in Biological Diversity·J M EstesG Gabbiani
Feb 1, 1994·The Journal of Cell Biology·F Grinnell
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·S K MasurS Petridou
Jul 22, 1998·Developmental Dynamics : an Official Publication of the American Association of Anatomists·A J CowinM W Ferguson
Jan 12, 2000·Burns : Journal of the International Society for Burn Injuries·V MoulinL Germain
Jan 31, 2003·World Journal of Surgery·Kelli M BullardH Peter Lorenz
Jul 26, 2003·Burns : Journal of the International Society for Burn Injuries·Paul P M van ZuijlenEsther Middelkoop
Sep 3, 2003·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Patricia A HebdaAlan Wells
Jun 16, 2004·Development·Paul Martin, Susan M Parkhurst
Aug 6, 2004·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Mark W J Ferguson, Sharon O'Kane
Aug 28, 2004·The American Journal of Pathology·Traci A WilgusTatiana M Oberyszyn
Jan 22, 2005·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Alexis DesmoulièreGiulio Gabbiani
Dec 13, 2005·The FEBS Journal·Angelika HorstmeyerThomas Krieg
Nov 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Giovanni FerrariPaolo Mignatti
Apr 17, 2007·The Journal of Investigative Dermatology·Sabine WernerHans Smola
May 26, 2007·The American Journal of Pathology·Boris HinzGiulio Gabbiani
Dec 15, 2007·Nature Protocols·Kazutoshi TakahashiShinya Yamanaka
Dec 19, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Ashley GordonTimothy M Crombleholme
Apr 23, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Traci A WilgusLuisa A Dipietro
May 16, 2008·Nature·Geoffrey C GurtnerMichael T Longaker
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Jun 27, 2008·The Journal of Investigative Dermatology·Jianfei WangEdward E Tredget
Sep 22, 2009·Current Biology : CB·Nimet Maherali, Konrad Hochedlinger
Dec 17, 2009·Nature Methods·Bryce W CareyRudolf Jaenisch
Oct 5, 2010·Plastic and Reconstructive Surgery·Barrett J LarsonH Peter Lorenz
Feb 2, 2011·The American Journal of Pathology·Hooman KhorasaniChia Soo
Feb 8, 2011·Journal of Cardiovascular Pharmacology·Jennifer Baum, Heather S Duffy
Nov 8, 2011·Genes & Development·Laure LapassetJean-Marc Lemaitre
Sep 25, 2012·Nature Reviews. Drug Discovery·Rosemary J Akhurst, Akiko Hata
Nov 14, 2012·Current Opinion in Cell Biology·Salah Mahmoudi, Anne Brunet
Jan 18, 2013·The Keio Journal of Medicine·Kazuo KishiYoshiaki Kubota
Aug 15, 2014·PloS One·Shin Ae ParkChristopher J Murphy

❮ Previous
Next ❯

Citations

May 14, 2019·Journal of Cellular Biochemistry·Mahmood Talkhabi
Jul 14, 2018·Stem Cells·Stuart P Atkinson
Aug 29, 2019·Regenerative Medicine·Michael D WestDana Larocca
Jan 9, 2021·Cell Stem Cell·Pradeep ReddyJuan Carlos Izpisua Belmonte
Jun 21, 2020·Experimental Gerontology·Aurélie ChicheHan Li
May 1, 2021·Genes·Dana LaroccaHal Sternberg
May 1, 2021·International Journal of Molecular Sciences·Quentin AlleJean-Marc Lemaitre
Apr 24, 2021·Burns : Journal of the International Society for Burn Injuries·Sina KardehShima Faezi-Marian
Dec 24, 2021·Advances in Wound Care·Alvis ChiuFeng Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.